NOTCH and EZH2 collaborate to repress PTEN expression in breast cancer
Pappas et al. show that the combination of NOTCH and EZH2 alterations drive transcriptional repression of PTEN through reversible epigenetic modification of the PTEN promoter. These results suggest an actionable target for treating poor-prognosis breast cancer.
Guardado en:
Autores principales: | Kyrie Pappas, Tiphaine C. Martin, Andrew L. Wolfe, Christie B. Nguyen, Tao Su, Jian Jin, Hanina Hibshoosh, Ramon Parsons |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0d639da6ef5d412789a11baff7e2a9fe |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
EZH1 and EZH2 promote skeletal growth by repressing inhibitors of chondrocyte proliferation and hypertrophy
por: Julian C. Lui, et al.
Publicado: (2016) -
Protein lysine 43 methylation by EZH1 promotes AML1-ETO transcriptional repression in leukemia
por: Liping Dou, et al.
Publicado: (2019) -
Inhibition of Notch pathway arrests PTEN-deficient advanced prostate cancer by triggering p27-driven cellular senescence
por: Ajinkya Revandkar, et al.
Publicado: (2016) -
Notch signaling represses cone photoreceptor formation through the regulation of retinal progenitor cell states
por: Xueqing Chen, et al.
Publicado: (2021) -
Ezh2 programs TFH differentiation by integrating phosphorylation-dependent activation of Bcl6 and polycomb-dependent repression of p19Arf
por: Fengyin Li, et al.
Publicado: (2018)